Cannabinoids in the Cardiovascular System
Authors:
- 1 January 2017
- book chapter
- Published by Elsevier
- Vol. 80, 329-366
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- The immunology of stroke: from mechanisms to translationNature Medicine, 2011
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?Progress in Lipid Research, 2011
- Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryFree Radical Biology and Medicine, 2011
- Inhibitor of Fatty Acid Amide Hydrolase Normalizes Cardiovascular Function in Hypertension without Adverse Metabolic EffectsChemistry & Biology, 2010
- Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null miceAtherosclerosis, 2010
- Pharmacological characterization of GPR55, a putative cannabinoid receptorPharmacology & Therapeutics, 2010
- The emerging role of the endocannabinoid system in cardiovascular diseaseSeminars in Immunopathology, 2009
- The future of endocannabinoid-oriented clinical research after CB1 antagonistsPsychopharmacology, 2009
- Inhibition of fatty acid amide hydrolase produces PPAR‐α‐mediated analgesia in a rat model of inflammatory painBritish Journal of Pharmacology, 2008
- ‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptorsBritish Journal of Pharmacology, 2008